Background
At-risk populations such as people who inject drugs (PWID), sex workers (SW), men who have sex with men (MSM) and HIV serodiscordant couples are highly exposed to HIV infection. However, despite multiple exposures, many of these individuals remain HIV seronegative; they are referred to as HIV-exposed seronegative (HESN). In sub-Saharan Africa, an important proportion of new HIV infections occur among heterosexual serodiscordant couples (HSDC) [1] [2] . These populations are of particular interest to identify markers of susceptibility to HIV or protection against infection. One of these markers may be the level of immune activation (IA), which is known to drive infection [3] [4] [5] [6] .
IA corresponds to the activation of the cellular components of the immune system, which results in systemic inflammation. It is usually assessed by the expression of cellular or soluble markers derived from reactions of innate or adaptive immune responses [7] [8] . The role of IA in the pathogenesis of HIV infection has been studied; it was found to be associated with HIV disease progression, increased morbidity and mortality [7] [9] [10] . Mucosal and systemic IA have also been demonstrated in HESN [11] , although its role and impact on HIV susceptibility are not elucidated. It is suggested that level of sexual exposure despite being refractory to infection generates IA in HESN [11] [12] [13] . Compared to people living with HIV (PLHIV), similar or lower levels of IA were reported in HESN [14] [15] [16] [17] . Compared to HIV-neg Controls, some studies reported higher levels of IA in HESN [11] [16] [18] [19] while others reported lower levels [20] - [25] , To gain further insight into IA in serodiscordant couples, we aimed to compare the levels (using beta 2 microglobulin (β 2 m) as a soluble marker of IA) between HESN, their HIV+ counterparts and HIV-neg Controls; then analyze the association of IA levels and sexual exposure to HIV (SEHIV).
Methods

Context
This study was conducted in Senegal, a West African country with a concentrated HIV epidemic: HIV prevalence is low (0.7%) among pregnant women but high in at-risk populations, reaching 9.4% among PWID, 17.8% among MSM 
R E T R A C T E D
Subjects' Recruitment and Data Collection
HSCD and HIV-neg controls were recruited in a cross-sectional study between November 2013 and February 2014 at the Fann University teaching hospital. In this hospital, there are two national reference centers for the care of PLHIV from where the Serodiscordant Cohort was established: the "Department of infectious and tropical diseases/Regional Research and Training Center for the care of HIV and associated diseases (SMIT/CRCF)" and the "Ambulatory Treatment Center (CTA)". Individuals were eligible if 1) they were aged ≥ 18 years, 2) they were married or living with an HIV serodiscordant partner for ≥six months, 3) one partner was confirmed HIV seropositive; 4) the other partner was confirmed HIV seronegative; 5) everyone signed an informed consent form. A group of HIV negative seroconcordant couples was also recruited as Controls (HIV-neg Controls) in the same facilities. They were recruited consecutively from couples who presented to the lab for HIV testing. They were eligible if: 1) they were aged ≥ 18 years, 2) they were married or living together for more than six months, 3) both partners were confirmed HIV seronegative; 4) everyone signed an informed consent form. The cross-sectional study population therefore constituted three groups: HIV-neg Controls (HIV-seroconcordant couples), HESN (HIV-partners from discordant couples) and HIV+ Partners (HIV+ partners from discordant couples). Questionnaires on sociodemographic characteristics and sexual practices were administered for all study participants accompanied by routine clinical examinations and blood sampling.
The study protocol was approved by the institutional ethical and research re- 
Beta-2-Microglobulin, CD4, CD8 and Viral Load Measurement
Plasma levels of β 2 m were measured using the integrated automated Abbott Architect ci4100 system (Abbott Laboratories, Wiesbaden, Germany) in accordance with the instructions of the manufacturer; using Quantia β 2 m reagents under calibrated conditions. Thawed plasma samples that were collected in EDTA tubes were used for a single time point assessment. The results are expressed in mg/L of β 2 m based on the WHO International Standard [30] .
CD4+ and CD8+ T cell counts of all participants were determined using the FACSCount System (BD Biosciences). HIV-1 and HIV-2 RNA levels were measured by the Biocentric ultrasensitive RNA viral load assay with a lower detection limit of 50 copies/mL.
Statistical Analysis
The different characteristics of the study population were described by HIV exposure and infection (HIV-neg Controls, HESN and HIV+ groups). Comparisons of categorical variables were done using Chi 2 test. The continuous variables were compared between two groups by t-test (all the expected number > 30 or one expected number < 30 with a normal distribution of the variable) or Mann Whitney/Wilcoxon test (one expected number < 30 with a non-normal distribution of the variable). The comparisons of continuous variables between three groups were done using Anova (normal distribution of the variables and equal variances) or Krusskal Wallis test elsewhere.
The association between study groups and β 2 m level was analysed by a logistic regression model (cut-off point = median of β 2 m was 2.02 mg/L). We estimated crude and adjusted measures of associations (Odd ratios) with 95% confidence intervals (CI). Confounding was controlled using a 10% change in estimate method (variables that change the estimate by ≥|10%| were included in the model) among the following potential confounders: age (18 -32/33 -39/40 -49/50 -68), sex (male vs female), education level (absence/elementary/high school/university), MRDR-estimated glomerular filtration rate (eGFR) (continuous), presence of comorbidity (yes/no), HBs antigen positivity (yes/no). Age, sex, presence of comorbidity and HBs antigen positivity were tested as effect modifiers. We also used the same methodology to evaluate the association using linear regression.
In the second part, the association between SEHIV and β 2 m level was evaluated among HIV susceptible individuals (HIV-neg Controls and HESN). We used different logistic regression models with SEHIV as exposure variable (presence versus absence and high versus low) and β 2 m level as outcome variable (cut-off points = median (1.48 mg/L) and third quartile (2.20 mg/L)) including previous potential confounders as well as the practice of anal sex (yes/no), the practice of oral sex (yes or no), the existence of occasional sexual(s) partner(s) (yes/no) and the HIV status of the partner (HIV-or HIV+); and in the latter case: duration of HIV infection (continuous), WHO clinical stage (1 or 2 or 3 or 4), pVL (<50 or ≥50), history of therapeutic failure (yes or no). Age, sex, practice of anal sex and existence of occasional sexual partners were tested as effect modifiers. We also repeated the analysis using linear regression. Table 1 shows the characteristics of study population: 54 HSDC (108 participants) and 20 HIV negative seroconcordant couples (40 participants). The mean ages of HESN and HIV+ were similar but were higher than those of HIV-neg Controls. Among the HSDC, the male partner was less likely to be HIV+ (40.7% versus 59.3%; p = 0.054). All the HIV+ participants were receiving antiretroviral therapy (ART). Among them, three had experienced therapeutic failure and were switched on second-line therapy. 
R E T R A C T E D
Results
Study Population
R E T R A C T E D
Association of β2m Level and Study Group
Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI)) for the association between β 2 m and study group (determined by comparisons in the study subject categories) are presented in Table 2 . The β 2 m level was dichotomized with the median value as the cut-off point: >2.02 mg/l or ≤2.02 mg/l.
After adjustment on age and sex, Plasma β 2 m was higher in exposed unin- None of the following variables was found to modify the effect of study group on β 2 m level: age (p = 0.110), sex (p = 0.665), presence of comorbidity (p = 0.435) and HBs antigen carriage (p = 0.996). All these results were similar using linear regression model (Table 3 ). ies/mL (p = 0.961); 2.15 mg/L versus 2.08 mg/L at a cut-off point of 10,000 copies/mL (p = 0.898).
Association of β2m
The results of the logistic regressions evaluating the association between a moderate to high β 2 m level (β 2 mmh) and SEHIV are presented in Table 4 . After ad- justment, neither the presence (aOR = 1.09; p = 0.895), nor the frequency of SEHIV (aOR = 2.08; p = 0.222) were associated with measure of β 2 m mh (Table 4 ).
R E T R A C T E D
However, with the use of a second set of logistic regression models analysing the third quartile of β 2 m level as the cut-off point (β 2 m level was considered high if >2.2 mg/l); the association between the presence of SEHIV and a β 2 m h was statistically significant (aOR = 5.36; p = 0.028) as well as the association between the frequency of SEHIV and a β 2 m h (aOR = 6.56; p = 0.006) ( Table 5 ).
The linear regression models found regression coefficients of 0.233 (p = 0.054) and 0.564 (p = 0.003), respectively ( Table 6 ). None of the following variables was found to be an effect modifier: age (p = 0.358), sex (p = 0.603) and existence of occasional sexual partners (p = 0.802). 
Discussion
We conducted a cross-sectional study on 54 HSDC and 20 HIV-negative seroconcordant couples in Senegal. We found that the IA levels (plasma level of β 2 m) in HIV+ individuals and HESN were not different but, both were higher than the level observed in HIV unexposed uninfected people. Our study also found an association between exposure to HIV through frequency of unprotected sex with an infected partner and a high level of IA; not a moderate level.
The interpretation of our results should consider several limitations: 1) our study was cross-sectional and such design does not permit to establish the temporal sequence between SEHIV and β 2 m level; although SEHIV was evaluated in the six months preceding the measurement of β 2 m level; 2) SEHIV was evaluated based on information given by study subjects and they could have under or miss-reported the frequency of unprotected sex, the practice of anal sex and extra-marital sex due to social desirability; 3) in logistic regression models, β 2 m levels were primarily categorized using the median levels, which fell in the normal range of β 2 m (0.97 -2.67 mg/L) [31] . However, these potential classification errors were non-differential and would only underestimate the measures of association. The observation of higher IA in HESN than HIV negative controls and similar to those of HIV+ individuals is consistent with some previous studies such as found in HSDC [11] [18] and PWID [16] . In accordance with our results, some studies also reported that HESN such as HSDC [14] , FSW [18] , and MSM [19] presented with higher levels of IA than unexposed or low-risk HIV individuals.
R E T R A C T E D
In an Amsterdam cohort, the pre-seroconversion T CD4 IA level was found lower among highly exposed MSM who remained HIV seronegative compared to their infected counterparts [17] . The similar IA levels in HESN and HIV+ as different from the normal levels in HIV-neg Control individuals was still observed following adjusted analyses that considered age and sex differences although we did not account for specific localised mucosal IA in the comparisons, which could affect IA in African populations [32] [33] .
Our observations are however at variance with results showing lower levels of IA in HESN in comparison with HIV+ infected individuals [15] or in comparison with HIV-unexposed or low-risk individuals [20] [21] [22] [23] [24] . These previous studies that showed low IA in HESN did not demonstrate adjusted analyses. The reduced level of IA reported in ESN is related to quiescent status of the immune system that is less activable than in HIV-neg Controls. This phenomenon called "immune quiescence" may contribute to resistance to HIV-infection [25] [34] [35] .
In our study, we categorised frequency of exposure by grouping into low exposure and high exposure based on information of a number of unprotected sex/month. Though social inhibition to divulge information about sexual activity is common in this society, we were able to analyse such available data. We found that the frequency of exposure to sexual activity to HIV+ partner (SEHIV) was associated with a high level of IA. This result suggests that there is exposure to the HIV virus and that exposure does impact on immune reaction at a certain level but the negative partner remains seronegative. There are two possible explanations. One one hand, it may be that the study population have high IA level because they are exposed to HIV but are not HIV resistant. The maintenance of an HIV seronegative status may be related to their exposure levels being low enough to allow for maintained seronegativity by chance as the per act chance of seroconversion is in the range of 3/1000. On the other hand, one proportion of the study population with low IA level irrespective of SEHIV was "immune quiescent" while the other with high IA level associated with SEHIV is at-risk of HIV infection. It will require a long term follow up to analyse if these individuals will succumb to break-through infection or that the IA is the triggered immune mechanism that protects against infection. Different studies found a relation between IA and different measures of sexual exposure to HIV: a previous report in Senegal, showed a negative correlation between CD4+/CD38+ T cell frequency and condom use among HESN [22] that did not account for duration of sexual relationship or the frequency of sex. This is similar to other reports that linked virus exposure in HIV negative individuals in various populations and [15] . However, some limitations of these studies were the use of an unreliable measurement of SEHIV, the low samples' sizes and the lack of adjustment on potential confounders.
Relationship between SEHIV and immune response or activation in the uninfected persons is difficult to interpret. It may require the assessment of several time point follow up of both HIV+ specific cellular responses and IA markers.
Many studies showed the role of HIV+ specific responses in exposed uninfected individuals on account of triggered IA in sex workers [14] [33] [36] , and MSM [37] , but HIV correlates of protection still remain elusive although a growing body of evidence is supporting the phenomenon of immune quiescence [25] [34] [35] .
It has been reported that IA is possible in HESN in HSDC even in the case of viral control in the HIV+ partner [15] . Though all of our HIV+ patients were under ART for viral suppression, the majority had a detectable pVL and the IA level was high in presence of viral replication of the partner. It would have been interesting to evaluate the adjusted association between pVL and IA but we were not enough powered to do it although such an association has been established by several studies [12] [15] . To what level plasma IA markers is influenced by the presence of viral load in positive partners will continue to generate interest in the context of frequencies of breakthrough infections in HESN vis-à-vis protection from infection. Understanding the influence of IA in the context of viral load may aid the identification of at-risk HIV uninfected population of potential breakthrough infection and therefore call for more preventive measures.
Moreover, from a public health perspective, it is important to identify most at risk HESN based on epidemiological characteristics in the absence of sophisticated biological parameters. These latter might not be available in several cases including occasional sex with an HIV+ partner, insufficiency of resources as it is frequently the case in some poor settings.
Our assessment of IA in HESN, though exploratory has been aided by the good sample size from our cohort and patient data that allowed adjustments for confounders in the statistical analyses. Since SEHIV is the main risk factor for HIV transmission in HSDC and IA is critical in the susceptibility to HIV infection [22] [38] , it was important to explore the association between SEHIV and IA. This was our objective and our results indicate an association between SEHIV and a high level of IA.
In our study, HESN presented with a median level of β 2 m similar to that of HIV+ partners but higher than that of HIV-neg controls. The level of β 2 m in HIV-neg persons appears to be associated with SEHIV and the relationship seems to mirror the one between IA and HIV acquisition. However, our study was exploratory and the results must be interpreted with caution. Despite these limitations and in accordance with existing literature, our study seems to indicate two profiles of HESN: those with an immune quiescent status and those with SEHIV, the differences between these two profiles must be more studied. A longitudinal study with a deep analysis of the dynamics of SEHIV and IA would be necessary for this purpose.
